bioRxivBiochemistryPreprint
Assembly-active and -inactive forms of HBV capsid protein provide distinctly different binding sites for capsid assembly modulators
Liam W. ScottiD, Carolina Pérez-SeguraiD, Jodi A. Hadden‐PerillaiD, Adam ZlotnickiD
Abstract
In an infection, Hepatitis B Virus (HBV) core protein (HBc) normally assembles into icosahedral capsids. Capsid Assembly Modulators (CAMs) are direct acting antivirals that induce HBc mis-assembly and are the subject of active research and development. Two versions of HBc are used in structural studies of CAM-HBc complexes: Cp150 and Cp149-Y132A. Cp150 forms empty icosahedral capsids that are structurally indistinguishable from those found in virions. The Y132A mutation of Cp149 leads to an assembly defective soluble protein that crystalizes as flat hexagonal sheets, where the hexagons resemble icosahedral quasi-sixfold vertices. In this study, we compare structures of CAM-bound Cp150 to CAM-bound Cp149-Y132A. In capsids, the residues forming the CAM site shift to match the structure of bound CAMs, an induced fit. In Cp149-Y132A crystals, CAM sites show little structural adjustment in response to different CAMs binding. In turn, the array of residues that interact with CAMs varies from CAM to CAM in capsid structures but remains nearly constant in Cp149-Y132A crystals. These results illustrate important differences between CAM binding in Cp149-Y132A and Cp150 structures that will contribute to future CAM design.
- assay: structural biology
- research focus: protein folding & dynamics
- research focus: cell type annotation
- approach: experimental assay
- approach: microscopy & imaging analysis
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Molecular elucidation of drug-induced abnormal assemblies of the Hepatitis B Virus capsid protein by solid-state NMR
L. Lecoq, L. Brigandat, … A. Bockmann·bioRxiv·Sep 14, 2022
- Mechanistic insights into CAM-induced disruption of HBV capsids revealed by all-atom MD simulations
Carolina Pérez-Segura, Boon Chong Goh, Jodi A. Hadden‐Perilla·PLoS PathogensPeer-reviewed·Feb 9, 2026
- Mechanism of action of HBV capsid assembly modulators predicted from binding to early assembly intermediates
Anna Pavlova, Leda Bassit, … James C. Gumbart·bioRxiv·Mar 23, 2020
- Modeling Reveals How Direct-Acting Antivirals Redirect HBV Capsid Assembly Pathways to Noninfectious Products
Layne B. Frechette, Smriti Pradhan, … Michael F. Hagan·bioRxiv·May 26, 2026
- Core Protein-Directed Antivirals and Importinβ Can Synergistically Disrupt HBV Capsids
C. Kim, L. F. Barnes, … A. Zlotnick·bioRxiv·Aug 16, 2021
- Structural Differences Between the Woodchuck Hepatitis Virus Core Protein in Dimer and Capsid States Indicate Entropic and Conformational Regulation of Assembly
Z. Zhao, J. C.-Y. Wang, … A. Zlotnick·bioRxiv·Jan 4, 2019